ClinicalTrials.Veeva

Menu

Evaluation of the Safety and Performance of the TriOSS®: A Retrospective Observational Study in Orthopaedic Area (TriOSSOrto01)

B

Bioceramed

Status

Terminated

Conditions

Orthopedic
Bone Defect

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT07087509
TriOSSOrto01

Details and patient eligibility

About

This study aims to collect real-world clinical data to gather information on the performance and safety of the TriOSS® when used according to its intended purpose and current clinical applications. The results of the clinical study will serve as clinical evidence for the device's clinical evaluation.

Enrollment

23 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult males or females (age > 18 years old);
  • Patients with osseous defects, either of trauma origin, surgically created, or associated with spinal degenerative diseases that require segmental fusion of the spine.
  • Patients with bone skeletal defects that are not intrinsic to the stability of the bone structure.

Exclusion criteria

  • Signs of local or systemic acute/ active or chronic infections;
  • Metabolic affections;
  • Severe degenerative diseases, conditions in which general bone grafting is not advisable;
  • Implementation sites that allow product migration;
  • Conditions which require structural support in the skeletal system;
  • Conditions where the implantation site is unstable and not rigidly fixated;
  • Sensibility to the implantable materials;
  • Known hypersensitivity to the implant material.

Trial contacts and locations

1

Loading...

Central trial contact

Alexandre Barros

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems